INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 135 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $600,000 | +212.5% | 11,467 | -8.0% | 0.00% | +100.0% |
| Q1 2020 | $192,000 | -75.6% | 12,467 | -45.7% | 0.00% | -50.0% |
| Q4 2019 | $788,000 | -24.0% | 22,967 | -83.4% | 0.00% | -33.3% |
| Q3 2019 | $1,037,000 | -51.6% | 138,767 | -15.9% | 0.00% | -40.0% |
| Q2 2019 | $2,141,000 | +39.7% | 164,967 | +31.1% | 0.01% | +25.0% |
| Q1 2019 | $1,533,000 | +376.1% | 125,867 | +345.3% | 0.00% | +300.0% |
| Q4 2018 | $322,000 | – | 28,267 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |